tiprankstipranks
Trending News
More News >

Fulgent Genetics sees FY25 EPS (65c), consensus (46c)

Sees FY25 core revenue $310M, consensus $324.21M. Paul Kim, CFO, said, “We are pleased with our financial performance in 2024 and believe we have entered 2025 in a position of strength, with projected growth in our laboratory services business and a strong balance sheet to execute our objectives.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1